Protocol for the Optimizing Naloxone Dispensing in Pharmacies (ONDP) Online Continuing Education Program: A Randomized Controlled Trial
The number of opioid-related deaths in Canada has steadily increased since 2016 and the COVID-19 pandemic has worsened this trend. Naloxone has been pivotal for reducing opioid-related harms and death, and pharmacists play a crucial role in ensuring the supply of naloxone to Canadians through commun...
Main Authors: | Ashley Cid, Alec Patten, Michael Beazely, Kelly Grindrod, Jennifer Yessis, Feng Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/10/1/24 |
Similar Items
-
Investigating Community Pharmacy Take Home Naloxone Dispensing during COVID-19: The Impact of One Public Health Crisis on Another
by: George Daskalakis, et al.
Published: (2021-07-01) -
What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review
by: Ashley Cid, et al.
Published: (2021-02-01) -
Adapting the Opening Minds Stigma Scale for Healthcare Providers to Measure Opioid-Related Stigma
by: Ashley Cid, et al.
Published: (2024-07-01) -
Assessing pharmacy student experience with, knowledge of and attitudes towards harm reduction: illuminating barriers to pharmacist-led harm reduction
by: Lily Rowan Mahon, et al.
Published: (2018-11-01) -
Naloxone availability in independent community pharmacies in Georgia, 2019
by: Lauren Gilbert, et al.
Published: (2021-08-01)